Zoetis Inc.

Zoetis Inc. is a global animal health company focused on manufacturing and commercializing veterinary medicines, vaccines, diagnostics, biopharmaceuticals, and digital solutions. The company serves veterinarians, livestock producers, and pet owners across companion animals and livestock sectors including dogs, cats, horses, cattle, swine, poultry, sheep, and aquaculture species. Its broad product portfolio spans major categories such as parasiticides, dermatology treatments, anti-infectives, vaccines, pain management, and AI-powered diagnostic platforms. Key proprietary brands include Librela, Solensia, Simparica Trio, Apoquel, Cytopoint, Revolution Plus, and Draxxin KP. Zoetis operates manufacturing facilities and research facilities worldwide, serving customers in over 100 countries. The organization provides veterinary medical information support, diagnostic services, clinical trial collaboration, and digital livestock analytics. Zoetis delivers continuous innovations predicting, preventing, detecting, and treating diseases across the continuum of care.